Orbimed Advisors LLC Reduces Stake in Passage Bio Inc

Published on 21 Sep 2024 on GuruFocus.com · via Yahoo Finance

Orbimed Advisors LLC Reduces Stake in Passage Bio Inc

Overview of Recent Transaction

On September 18, 2024, Orbimed Advisors LLC executed a significant transaction by reducing its holdings in Passage Bio Inc (NASDAQ:PASG), a company focused on genetic medicines for CNS disorders. The firm sold 2,290,707 shares, resulting in a decrease of 22.63% from its previous holding, bringing its total shares to 7,833,869. This move impacted the firm's portfolio by a mere -0.03%, with the shares traded at a price of $0.73 each.

Profile of Orbimed Advisors LLC

Read the rest of the article

NASDAQ.PASG price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

WuXi Firms Surge on Slimmer Chances of US Biosecure Passage

(Bloomberg) -- Shares of Chinese biotech service providers WuXi AppTec Co. and WuXi Biologics Cay...

Bloomberg · via Yahoo Finance 9 Dec 2024

Orbimed Advisors LLC Reduces Stake in Passage Bio Inc

Overview of Recent Transaction On September 18, 2024, Orbimed Advisors LLC executed a significant...

GuruFocus.com · via Yahoo Finance 21 Sep 2024

All You Need to Know About Passage Bio (PASG) Rating Upgrade to Buy

Passage Bio, Inc. (PASG) could be a solid choice for investors given its recent upgrade to a Zack...

Zacks via Yahoo Finance 17 May 2024

Passage Bio, Inc. (PASG) Is Up 24.26% in One Week: What You Should Know

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 8 Mar 2024

WuXi AppTec, WuXi Bio Tumble After US Panel Advances Ban Bill

(Bloomberg) -- WuXi AppTec Co. tumbled after a US Senate committee advanced a bill that may ban...

Bloomberg via Yahoo News 7 Mar 2024

Lyra (LYRA) Posts Upbeat Data on Rhinosinusitis Study, Stock Up

Lyra Therapeutics LYRA reported positive data from the ongoing phase II BEACON study, evaluating ...

Zacks via Yahoo Finance 14 Sep 2023

Passage Bio, Inc. (NASDAQ:PASG) Q4 2022 Earnings Call Transcript

Passage Bio, Inc. (NASDAQ:PASG) Q4 2022 Earnings Call Transcript March 6, 2023 Operator: Good mor...

Insider Monkey via Yahoo Finance 8 Mar 2023

Philadelphia-area public companies lost $186B in value in 2022. These were the biggest winners and...

Publicly traded companies in the region collectively lost more than $186 billion in market value...

American City Business Journals 10 Jan 2023

After losing 67% in the past year, Passage Bio, Inc. (NASDAQ:PASG) institutional owners must be...

To get a sense of who is truly in control of Passage Bio, Inc. (NASDAQ:PASG), it is important to ...

Simply Wall St. via Yahoo Finance 7 Jan 2023

15 Most Shorted Stocks Hedge Funds Are Buying

In this article, we will discuss the 15 most shorted stocks hedge funds are buying. You can skip ...

Insider Monkey via Yahoo Finance 28 Dec 2022